Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Butturini

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Pediatric Blood & Cancer|February 11, 2010
The challenges of high-dose chemotherapy in CNS tumorsAnna Butturini, Didier Frappaz
Leukemia Research|January 18, 2003
Modeling minimal residual disease (MRD)-testingAnna Butturini, John Klein, Robert Peter Gale
Journal of Pediatric Hematology/Oncology|January 7, 2004
Approaches to treatment for extraocular retinoblastoma: Children's Hospital Los Angeles experienceRima F Jubran, Anat Erdreich-Epstein, Anna Butturini, et al.
Cancer Research|April 16, 2013
Adipocytes cause leukemia cell resistance to L-asparaginase via release of glutamineEhsan A Ehsanipour, Xia Sheng, James W Behan, et al.
Pediatric Blood & Cancer|August 20, 2013
Infectious complications in the first year following autologous hematopoietic progenitor cell rescue for children with brain tumorsRobert J Brown, Hussein Rahim, Kenneth E Wong, et al.
Cancer Prevention Research (Philadelphia, Pa.)|September 9, 2010
Diet-induced obesity accelerates acute lymphoblastic leukemia progression in two murine modelsJason P Yun, James W Behan, Nora Heisterkamp, et al.
Pediatric Blood & Cancer|July 16, 2015
Comparative Toxicity by Sex Among Children Treated for Acute Lymphoblastic Leukemia: A Report From the Children's Oncology GroupKathleen A Meeske, Lingyun Ji, David R Freyer, et al.
Blood Advances|April 19, 2024
Acalabrutinib-based regimens in frontline or relapsed/refractory higher-risk CLL: pooled analysis of 5 clinical trialsMatthew S Davids, Jeff P Sharman, Paolo Ghia, et al.
Cancer Research|September 24, 2009
Adipocytes impair leukemia treatment in miceJames W Behan, Jason P Yun, Marina P Proektor, et al.
Nature|February 14, 2019
Author Correction: HER kinase inhibition in patients with HER2- and HER3-mutant cancersDavid M Hyman, Sarina A Piha-Paul, Helen Won, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Pediatric Blood & Cancer|February 11, 2010
The challenges of high-dose chemotherapy in CNS tumorsAnna Butturini, Didier Frappaz
Leukemia Research|January 18, 2003
Modeling minimal residual disease (MRD)-testingAnna Butturini, John Klein, Robert Peter Gale
Journal of Pediatric Hematology/Oncology|January 7, 2004
Approaches to treatment for extraocular retinoblastoma: Children's Hospital Los Angeles experienceRima F Jubran, Anat Erdreich-Epstein, Anna Butturini, et al.
Cancer Research|April 16, 2013
Adipocytes cause leukemia cell resistance to L-asparaginase via release of glutamineEhsan A Ehsanipour, Xia Sheng, James W Behan, et al.
Pediatric Blood & Cancer|August 20, 2013
Infectious complications in the first year following autologous hematopoietic progenitor cell rescue for children with brain tumorsRobert J Brown, Hussein Rahim, Kenneth E Wong, et al.
Cancer Prevention Research (Philadelphia, Pa.)|September 9, 2010
Diet-induced obesity accelerates acute lymphoblastic leukemia progression in two murine modelsJason P Yun, James W Behan, Nora Heisterkamp, et al.
Pediatric Blood & Cancer|July 16, 2015
Comparative Toxicity by Sex Among Children Treated for Acute Lymphoblastic Leukemia: A Report From the Children's Oncology GroupKathleen A Meeske, Lingyun Ji, David R Freyer, et al.
Blood Advances|April 19, 2024
Acalabrutinib-based regimens in frontline or relapsed/refractory higher-risk CLL: pooled analysis of 5 clinical trialsMatthew S Davids, Jeff P Sharman, Paolo Ghia, et al.
Cancer Research|September 24, 2009
Adipocytes impair leukemia treatment in miceJames W Behan, Jason P Yun, Marina P Proektor, et al.
Nature|February 14, 2019
Author Correction: HER kinase inhibition in patients with HER2- and HER3-mutant cancersDavid M Hyman, Sarina A Piha-Paul, Helen Won, et al.
Pageof 2